AU5047600A - Mammalian interleukin-10 homologs: il-d110 and il-d210 - Google Patents

Mammalian interleukin-10 homologs: il-d110 and il-d210

Info

Publication number
AU5047600A
AU5047600A AU50476/00A AU5047600A AU5047600A AU 5047600 A AU5047600 A AU 5047600A AU 50476/00 A AU50476/00 A AU 50476/00A AU 5047600 A AU5047600 A AU 5047600A AU 5047600 A AU5047600 A AU 5047600A
Authority
AU
Australia
Prior art keywords
homologs
mammalian interleukin
interleukin
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50476/00A
Inventor
Rene De Waal Malefyt
Nagalakshmi L. Marehalli
Christi L. Parham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU5047600A publication Critical patent/AU5047600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
AU50476/00A 1999-05-27 2000-05-26 Mammalian interleukin-10 homologs: il-d110 and il-d210 Abandoned AU5047600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32280699A 1999-05-27 1999-05-27
US09322806 1999-05-27
PCT/US2000/014729 WO2000073457A1 (en) 1999-05-27 2000-05-26 Mammalian interleukin-10 homologs: il-d110 and il-d210

Publications (1)

Publication Number Publication Date
AU5047600A true AU5047600A (en) 2000-12-18

Family

ID=23256501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50476/00A Abandoned AU5047600A (en) 1999-05-27 2000-05-26 Mammalian interleukin-10 homologs: il-d110 and il-d210

Country Status (2)

Country Link
AU (1) AU5047600A (en)
WO (1) WO2000073457A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016611A2 (en) * 2000-08-24 2002-02-28 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
US6551799B2 (en) 1999-12-07 2003-04-22 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
US7307161B1 (en) 1999-04-28 2007-12-11 Genetics Institute, Llc Human Gil-19/AE289 polynucleotides
US6939545B2 (en) 1999-04-28 2005-09-06 Genetics Institute, Llc Composition and method for treating inflammatory disorders
MXPA01010883A (en) * 1999-04-28 2002-10-31 Inst Genetics Llc Human gil-19/ae289 proteins and polynucleotides encoding same.
WO2001040467A1 (en) 1999-12-03 2001-06-07 Zymogenetics, Inc. Human cytokine receptor
US7226591B2 (en) 2000-05-22 2007-06-05 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
CA2395369C (en) * 1999-12-23 2014-07-08 Zymogenetics, Inc. Cytokine zcyto18
US20030012788A1 (en) 2000-07-27 2003-01-16 Jean-Christophe Renauld Method for influencing kinase pathways with IL-22
DE60129137D1 (en) * 2000-07-27 2007-08-09 Wyeth Corp MODULATION BY IL-TIF / INTERLEUKIN-21
JP5015404B2 (en) 2000-08-08 2012-08-29 ザイモジェネティクス， インコーポレイテッド Soluble ZCYTOR11 cytokine receptor
WO2002022153A2 (en) 2000-09-15 2002-03-21 Zymogenetics, Inc. Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7094570B2 (en) 2003-03-11 2006-08-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
US7638604B2 (en) 2001-02-23 2009-12-29 Genetics Institute, Llc Monoclonal antibodies against interleukin-22
US20040086908A1 (en) 2002-03-07 2004-05-06 Chandrasekher Yasmin A. Soluble heterodimeric cytokine receptor
CA2439961A1 (en) 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
WO2003051384A1 (en) 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating cervical cancer
CA2480163A1 (en) 2002-03-22 2003-10-09 Zymogenetics, Inc. Anti-il-tif antibodies and methods of using in inflammation
JP2007525437A (en) 2003-03-24 2007-09-06 ザイモジェネティクス， インコーポレイテッド Anti-IL-20 antibodies and binding partners and methods for use in inflammation
WO2005052001A2 (en) 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
BRPI0516975A (en) 2004-10-22 2008-09-30 Zymogenetics Inc antibody or antigen-binding fragment thereof, pharmaceutical composition, immunoconjugate, hybridoma, monoclonal antibody, and use of an antibody or antigen-binding fragment thereof
TW200744634A (en) 2006-02-21 2007-12-16 Wyeth Corp Methods of using antibodies against human IL-22
TWI417301B (en) 2006-02-21 2013-12-01 Wyeth Corp Antibodies against human il-22 and uses therefor
BR112015023140A8 (en) 2013-03-15 2018-01-23 Genentech Inc fusion proteins, fusion protein manufacturing method, compositions, nucleic acid, vector, host cell, methods of producing a fusion protein, treating inflammatory bowel disease, inhibiting microbial infection, treating kidney injury , to accelerate or improve healing, to prevent or treat a cardiovascular condition, to treat metabolic syndrome, and to treat endotoxemia.
EP3551034A1 (en) 2016-12-07 2019-10-16 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183931A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
CN113348011B (en) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 Method and apparatus for treating disease with biotherapeutic agents
CN115666704A (en) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 Ingestible device for delivery of therapeutic agents to the gastrointestinal tract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
WO2000073457A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU5047600A (en) Mammalian interleukin-10 homologs: il-d110 and il-d210
AU4943200A (en) Modified cytokine
AU1191201A (en) Elastic article
AUPQ419099A0 (en) Novel compositions and methods
AU3884701A (en) Cardiac methods and system
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU6364700A (en) Human synthetases
AU1890599A (en) Novel microorganism and use thereof
AU1890300A (en) Novel interferon-alpha
AU2678800A (en) Modified calycins
AU715620C (en) Therapeutic methods and uses
AU1403501A (en) Novel composition and use
AU3388400A (en) Human glycosylation enzymes
AU5132199A (en) Electroporation buffer with cryprotective capabilities
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AUPQ342599A0 (en) Conjugates and uses thereof
AU7752500A (en) Elastic articles and uses thereof
AU1083501A (en) Antibiotic-metal complex and methods
AU4923900A (en) Glass keyboard and use thereof
AU2621401A (en) Tracheotrode and tracheal electroventilation system
AU1894601A (en) Novel gene and use thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2669201A (en) Taccalonolides and their use
AU4456800A (en) Human hac3
AU7064500A (en) Human narcolepsy gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase